DK623684A - Flertrinskombinationspraeparat og dets anvendelse til oral kontraception - Google Patents

Flertrinskombinationspraeparat og dets anvendelse til oral kontraception Download PDF

Info

Publication number
DK623684A
DK623684A DK623684A DK623684A DK623684A DK 623684 A DK623684 A DK 623684A DK 623684 A DK623684 A DK 623684A DK 623684 A DK623684 A DK 623684A DK 623684 A DK623684 A DK 623684A
Authority
DK
Denmark
Prior art keywords
oral
contraction
combination preparation
application
step combination
Prior art date
Application number
DK623684A
Other languages
English (en)
Other versions
DK163209C (da
DK623684D0 (da
DK163209B (da
Inventor
Ursula Lachnit-Fixson
Renate Unger
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK623684D0 publication Critical patent/DK623684D0/da
Publication of DK623684A publication Critical patent/DK623684A/da
Publication of DK163209B publication Critical patent/DK163209B/da
Application granted granted Critical
Publication of DK163209C publication Critical patent/DK163209C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK623684A 1983-12-22 1984-12-21 To- eller tretrinskombinationspraeparat til oral kontraception DK163209C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833347125 DE3347125A1 (de) 1983-12-22 1983-12-22 Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
DE3347125 1983-12-22

Publications (4)

Publication Number Publication Date
DK623684D0 DK623684D0 (da) 1984-12-21
DK623684A true DK623684A (da) 1985-06-23
DK163209B DK163209B (da) 1992-02-10
DK163209C DK163209C (da) 1992-06-29

Family

ID=6218183

Family Applications (1)

Application Number Title Priority Date Filing Date
DK623684A DK163209C (da) 1983-12-22 1984-12-21 To- eller tretrinskombinationspraeparat til oral kontraception

Country Status (18)

Country Link
US (1) US4621079A (da)
EP (1) EP0148724B1 (da)
JP (1) JPS60169419A (da)
AT (1) ATE34665T1 (da)
AU (1) AU560487B2 (da)
CA (1) CA1252047A (da)
CY (1) CY1464A (da)
DE (2) DE3347125A1 (da)
DK (1) DK163209C (da)
FI (1) FI83288C (da)
HK (1) HK12289A (da)
IL (1) IL73889A (da)
MY (1) MY101778A (da)
NO (1) NO166756C (da)
NZ (1) NZ210626A (da)
PH (1) PH23373A (da)
SG (1) SG72588G (da)
ZA (1) ZA8410015B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE35724E (en) * 1982-04-28 1998-02-03 Bio-Technology General Corp. Contraception system and method
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
CA1336328C (en) * 1988-04-11 1995-07-18 Walter G. Leonard Method of increasing bone density in humans
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive
US6451778B1 (en) 1996-07-26 2002-09-17 Wyeth Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
US6479475B1 (en) 1996-07-26 2002-11-12 Wyeth Oral contraceptive
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6787531B1 (en) 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
EP2305267A3 (en) 1999-08-31 2011-08-17 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
DK1598069T3 (da) 1999-08-31 2009-07-06 Bayer Schering Pharma Ag Farmaceutisk præparat af ethinylestradiol og drospirenon til anvendelse som præventionsmiddel
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6660726B2 (en) * 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
CN1933873A (zh) * 2004-03-19 2007-03-21 沃纳奇尔科特公司 延长周期的多相口服避孕方法
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
CN101489563A (zh) 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
KR20100117603A (ko) * 2008-02-13 2010-11-03 바이엘 쉐링 파마 악티엔게젤샤프트 안정화 효과를 갖는 약물 전달 시스템
WO2009101021A2 (en) * 2008-02-13 2009-08-20 Bayer Schering Pharma Aktiengesellschaft Estradiol-containing drug delivery system
UY32836A (es) 2009-08-12 2011-03-31 Bayer Schering Pharma Ag Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
DE2431704A1 (de) * 1974-07-02 1976-01-22 Asche Ag Stufenkombinationspraeparate per kontrazeption
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
US4544554A (en) * 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DE3341638A1 (de) * 1983-11-17 1984-05-03 Hermann Dr.rer.nat. 8000 München Heßlinger Dreiphasen-praeparat zur empfaengnisverhuetung aus ethinyloestradiol und lynestrenol

Also Published As

Publication number Publication date
IL73889A0 (en) 1985-03-31
JPH0569810B2 (da) 1993-10-01
JPS60169419A (ja) 1985-09-02
HK12289A (en) 1989-02-17
SG72588G (en) 1989-05-26
US4621079A (en) 1986-11-04
ZA8410015B (en) 1985-08-28
NO166756C (no) 1991-09-04
AU560487B2 (en) 1987-04-09
FI83288C (fi) 1991-06-25
MY101778A (en) 1992-01-17
FI83288B (fi) 1991-03-15
DK163209C (da) 1992-06-29
DE3471589D1 (en) 1988-07-07
AU3701584A (en) 1985-07-04
NZ210626A (en) 1988-02-29
ATE34665T1 (de) 1988-06-15
NO166756B (no) 1991-05-27
CA1252047A (en) 1989-04-04
EP0148724B1 (de) 1988-06-01
DK623684D0 (da) 1984-12-21
DE3347125A1 (de) 1985-07-11
CY1464A (en) 1989-07-21
DK163209B (da) 1992-02-10
IL73889A (en) 1988-05-31
FI845065A0 (fi) 1984-12-20
NO845194L (no) 1985-06-24
EP0148724A1 (de) 1985-07-17
FI845065L (fi) 1985-06-23
PH23373A (en) 1989-07-14

Similar Documents

Publication Publication Date Title
DK623684A (da) Flertrinskombinationspraeparat og dets anvendelse til oral kontraception
GB2021123B (en) Surgical cements
AU8346082A (en) Methods and compositions for intravaginal contraception
IL72067A (en) 1-alkyl-androsta-1,4-diene-3,17-diones,processes for their preparation and pharmaceutical compositions containing the same
DE3471588D1 (en) Prostaglandins and antigestagens for the onset of labour or for the interruption of pregnancy
DE69024047D1 (de) Nimbaumöl enthaltende Zusammensetzung zur Fertilitätskontrolle und zur Schwangerschaftsverhütung.
GB2165750B (en) Oral contraceptive composition
GR75913B (da)
AU521407B2 (en) Gas fittings
DE3160507D1 (en) Process for the preparation of 3,20-dioxo-pregn-4-ene and/or 3,20-dioxo-pregna-1,4-diene
AU549895B2 (en) Accelerators for cementitious compositions
JPS57135747A (en) Adhesive quick-setting water-stopping cement
JPS5673654A (en) Waterrresistant agent for gypsum plaster* its manufacture and its use
JPS55104953A (en) Cement retarder for cold joint prevention
JPS57205373A (en) Low expansion heating body composition
JPS5576284A (en) Expansion pipe joint for highhtemperature and pressure
JPS57171186A (en) Cement pipe and manufacture thereof
KR910008596U (ko) 벽면부착 수동식 때밀이기구